Position in ETON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,256,067
-$176,212 QoQ
Shares Held
34,698
-40.2% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 163 holders
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. ETON ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,284,773 | $130,058,261 | |
| 2 | VTRS |
Viatris Inc
|
3,165,469 | $50,267,647 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,105,005 | $37,437,568 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
185,545 | $31,271,754 | |
| 5 | ZTS |
Zoetis Inc.
|
237,394 | $17,059,132 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
188,565 | $12,058,731 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
690,897 | $11,959,425 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
98,305 | $10,905,956 |
All Filings in ETON
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,256,067 | 34,698 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,432,279 | 58,034 | Shares | Sole | 2026-05-13 | |
| 2021-03-31 | $540,216 | 73,800 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $621,107 | 76,397 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||